Non-Hodgkin Lymphoma Clinical Trials

524 clinical trials for Non-Hodgkin Lymphoma across international registries, including 119 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma — RECRUITING · PHASE1
• Sample Collection for Ongoing Research and Product Evaluation Study - Non-Hodgkin Lymphoma (SCORE-NHL) — RECRUITING
• A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies — RECRUITING · PHASE1
• Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19) — RECRUITING · PHASE1
• A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy — RECRUITING · NA
• LV20.19 CAR T-Cells in Combination With Pirtobrutinib for Relapsed, Refractory B-cell Malignancies — RECRUITING · PHASE1
• Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU — RECRUITING
• A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy — RECRUITING · PHASE3
• A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma — RECRUITING · PHASE3
• Clinical Study of XNW5004 Combined With CHOP/CHOEP in the Treatment of Untreated Peripheral T-Cell Lymphoma — RECRUITING · PHASE1
• A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant — RECRUITING · PHASE1
• Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases — RECRUITING · PHASE2
• An Open-label, Single-arm Clinical Study to Evaluate the Safety and Preliminary Efficacy of OriV508 Injection in Treating Relapsed/Refractory Hematological Malignancies — RECRUITING · PHASE1
• Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas — RECRUITING · PHASE1
• Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial — RECRUITING · PHASE2
• Pre-malignant States to Hematologic Malignancies in Firefighters — RECRUITING
• Preliminary Safety and Tolerability of CD19x22 CAR T Cells in Adolescent and Adult R/R B-NHL Patients — RECRUITING · PHASE1
• A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) — RECRUITING
• Radiation, Oral Vancomycin, and CAR-T for B-Cell Lymphomas — RECRUITING · PHASE1
• Halt Aging in Survivors of Blood Cancers — RECRUITING · NA
• Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas — RECRUITING · PHASE1
• Study of Cytokine Release Syndrome Prophylaxis and Treatment With Siltuximab Prior to Epcoritamab — RECRUITING · PHASE1
• AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies. — RECRUITING · PHASE1
• Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies — RECRUITING · PHASE1
• Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma — RECRUITING · PHASE1
• Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors — RECRUITING
• Toxin Exposure and Immune Dysregulation in Non-Hodgkin Lymphoma — RECRUITING
• Familial Investigations of Childhood Cancer Predisposition — RECRUITING
• CD30 CAR T Cells, Relapsed CD30 Expressing Lymphoma (RELY-30) — RECRUITING · PHASE1
• Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution — RECRUITING
• A Phase I Study of JLM019 Injection — RECRUITING · PHASE1
• Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma — RECRUITING · PHASE1
• Cord Blood Transplantation in Children and Young Adults With Blood Cancer — RECRUITING · PHASE2
• IOMAB-CAR-T Followed by CAR-T Cell Therapy in R/R DLBCL — RECRUITING · PHASE1
• Phase II Study of Pirtobrutinib With Venetoclax In Relapsed-Refractory MCL (Mantle Cell Lymphoma) Patients — RECRUITING · PHASE2
• Methods of T Cell Depletion Trial (MoTD) — RECRUITING · PHASE2
• Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL. — RECRUITING · PHASE1
• Treatment of Chinese Participants With B-Cell Malignancies With BGB-16673, a Bruton Tyrosine Kinase-Targeted Protein-Degrader — RECRUITING · PHASE1
• Ibrutinib Combination Therapy in Transplant Ineligible Individuals With Newly Diagnosed Primary CNS Lymphoma — RECRUITING · PHASE2
• KSV01 Injection for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma — RECRUITING · PHASE1
• A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma — RECRUITING · PHASE2
• Improving Exercise Capacity With a Tailored Physical Activity Intervention — RECRUITING · NA
• Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics — RECRUITING
• CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma — RECRUITING · PHASE1
• GB5005 CART-cell Injection in the Treatment of Patients With CD19-positive RR B-NHL — RECRUITING · PHASE1
• Long-Term Follow-up Study — RECRUITING
• CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant — RECRUITING · PHASE2
• PIC1 Injection Therapy for Relapsed/Refractory B-NHL — RECRUITING · PHASE1
• A PHASE 1B/2 STUDY TO EVALUATE THE SAFETY AND EFFICACY OF MK-1045 MONOTHERAPY OR IN COMBINATION WITH OTHER ANTICANCER AGENTS IN PARTICIPANTS WITH NON-HODGKIN LYMPHOMA — RECRUITING · PHASE1
• SB-4826 in Adult Participants With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin Lymphomas — RECRUITING · PHASE1

Refine this search